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Impedance Versus Temperature Monitoring. Introduction: The purpose of this study
was to prospectively compare the value of impedance and temperature monitoring during ac-
cessory pathway ablation. Temperature and impedance monitoring can be used during ra-
diofrequency ablation of accessory pathways to titrate power to achieve adequate but not ex-
cessive tissue beating.
Methods and Results: One hundred thirty-two patients with a single accessory pathway were
randomly assigned to undergo ablation using either impedance monitoring or temperature
monitoring. During impedance monitoring, tbe endpoint for titration of power was a 5- to lO-fl
decrease in tbe measured impedance while for temperature monitoring the endpoint was to
achieve a temperature of 58° to 62°C. Two protocols were used. In protocol 1 (90 patients), im-
pedance monitoring was performed with a nonthermistor catheter and temperature monitor-
ing was performed with a thermistor catheter. In protocol 2 (42 patients), a thermistor catheter
was used in all patients. In protocol 1, the success rate (93% vs 93%; P = 1.0), ablation proce-
dure duration (57 ± 56 vs 41 ± 41 min), fluoroscopy time (48 ± 29 vs 41 ± 23 min; P = 0.3), num-
ber of applications (6.2 ± 4.7 vs 5.7 ± 4.6; P = 0.8), and tbe number of applications associated
with coagulum formation (0.1 ± 0.3 vs 0.3 ± 0.6; P = 0.1) were similar in the two groups. In pro-
tocol 2, as in protocol 1, tbere were no differences in the success rate (91% vs 95%; P = 1.0),
ablation procedure duration (49 ± 37 vs 62 ± 55 min; P = 0.4), fluoroscopy time (46 ± 24 vs 49 ±
36 min; P = 0.8), number of applications (6.8 ± 7.0 vs 7.8 ± 12.1; P = 0.7), or number of applica-
tions associated witb coagulum formation (0.3 ± 0.6 vs 0.2 ± 0.7; P = 0.6) between the imped-
ance and temperature monitoring groups.
Conclusion: Temperature and impedance monitoring are equally effective in optimizing
tbe results of accessory pathway ablation. (J Cardiovasc Electrophysiol, Vol. 7, pp. 795-801,
September 1996)
Wolff-Parkinson-White syndrome, thermistor ablation catheter, thermometry
Introduction
Tissue heating to approximately 6()°C is required
for successful catheter ablation of accessory
pathways using radiofrequency energy.'^ Because
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variables such as tissue contact pressure affect the
amount of power required to achieve adequate tis-
sue heating,'-'-' applications at a fixed power set-
ting may result in insufficient, sufficient, or ex-
cessive heating.
Two techniques can be used to titrate power to
attain appropriate tissue heating. These include
temperature monitoring'-^ and impedance moni-
toring.'' During temperature monitoring, the target
temperature for accessory pathway ablation is




































AP = accessory pathway; f = female; M = male.
approximately 60°C.'-2 During impedance moni-
toring, applications of radiofrequency energy as-
sociated with a drop in impedance of 5 to \0 Q
are associated with an electrode-tissue interface
temperature of approximately 60°C.''
The clinical utility of these techniques has not
been compared. Therefore, the purpose of this study
was to prospectively compare impedance and tem-
perature monitoring during radiofrequency catheter
ablation of accessory pathways.
Methods
Study Design
A comparison of temperature and impedance
monitoring was performed using two methodolo-
gies. In protocol I, a thermistor catheter was used
in patients randomized to temperature monitoring,
and a standard, nonthermistor ablation catheter was
used in patients randomized to impedance moni-
toring. This protocol reflects clinical practice, in
that a thermistor catheter was used only when tem-
perature monitoring was desired; otherwise, a stan-
dard nonthermistor catheter was used. However, in-
herent differences between the two types of catheters
could influence the results. Therefore, protocol 2
was also performed. In protocol 2, accessory
pathway ablation was always performed with the
thermistor catheter. However, the patients were ran-
domized to power titration guided by temperature
monitoring alone, or by impedance monitoring
alone. In patients randomized to impedance mon-
itoring, temperature data were not available to the
operators during the ablation procedure. Likewise,
impedance data were not available to the operators
when temperature monitoring was performed.
Characteristics of Subjects
One hundred thirty-two consecutive patients
with a single accessory pathway referred for catheter
ablation were enrolled under a protocol approved
by the Committee on Human Research at the Uni-
versity of Michigan. Ninety consecutive patients
were assigned to protocol I, and 42 consecutive
patients were assigned to protocol 2. In protocol
1, there were 46 men and 44 women (mean age
38 ± 14 years [ ± SD]). Only two patients had
structural heart disease. There were no significant
differences in clinical characteristics or accessory
pathway location between the patients randomized
to impedance and temperature monitoring (Table
1). In protocol 2, there were 28 men and 14 women
(mean age 37 ± 15 years). No patient had struc-
tural heart disease, and there were no significant
differences in accessory pathway location or clin-
ical characteristics between patients randomized to
impedance monitoring or temperature monitoring
(Table 2).
TABLE 2
Clinical Characteristics of Protocol 2 Patients





























AP = accessory pathway; f = female; M = male.
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Electrophysiologic Testing and Catheter Ablation
Electrophysiologic testing was performed with
quadripolar electrode catheters positioned in the
high right atrium, across the tricuspid valve to
record a His-bundle electrogram, and in the right
ventricular apex. Leads V,, I, n, and HI, and the
intracardiac electrograms were recorded on a Sie-
mans-Elema (Solna, Sweden) Mingograph 7
recorder. Mapping demonstrated that the accessory
pathway was located in the right free wall in 35
patients, the left wall in 71 patients, and the pos-
teroseptal area in 8 patients (Tables 1 and 2).
The techniques used for ablation have been pre-
viously described.''-'*' Ablation of right-sided and
septal accessory pathways was accomplished by
advancing the ablation catheter up the inferior vena
cava and positioning it on the atrial side of the tri-
cuspid annulus. For left-sided accessory pathways,
the catheter was inserted into a femoral artery,
passed across the aortic valve, and positioned on
the ventricular side of the mitral annulus.
Target sites for ablation were selected using pre-
viously established criteria." Ifthe accessory path-
way was manifest, mapping was performed dur-
ing sinus rhythm or atrial pacing. If the accessory
pathway was concealed, mapping of retrograde
atrial activation was accomplished during ortho-
dromic tachycardia or ventricular pacing. Stability
of the target site electrogram was required, with
stability being defined as < 10% variation in the
atrial or ventricular electrogram amplitude from
beat to beat.'''""
Ablation Catheters
Two different ablation catheters were used for
protocol 1. A 7-French quadripolar catheter with
a 4-mm distal electrode and a steerable shaft was
used in patients randomized to impedance moni-
toring (Mansfield EP, Watertown, MA, USA). A
7-French quadripolar electrode catheter with a
deflectable shaft in which a thermistor bead was
incorporated into the 4-nim distal electrode (EP
Technologies, Inc., Sunnyvale, CA, USA) was used
in patients randomized to temperature monitoring.
The thermistor bead was exposed to the surface
and thermally insulated from the surrounding plat-
inum electrode by a polyamide plastic sleeve. Each
catheter was individually calibrated and accurate
within 2° from 37° to 100°C. A previous study
demonstrated that a thennistor isolated from the
radiofrequency energy delivery electrode and in
contact with the endocardium accurately measures
the temperature at the electrode-tissue interface.'^
The thermistor catheter used in this study was eval-
uated clinically in a prior study and found to be
effective and accurate.' The impedance change
measurement was accurate to within ± 1 f2 for both
the nonthermistor and thermistor catheters.
Only the thermistor ablation catheter (EP Tech-
nologies) was used in protocol 2. Patients in pro-
tocol 2 were randomly assigned to radiofrequency
catheter ablation with temperature monitoring alone,
or with impedance monitoring alone. In patients
randomly assigned to temperature monitoring, only
the temperature was displayed to the operators of
the procedure. Likewise, the temperature data fnsm
patients randomly assigned to impedance moni-
toring were not displayed to the operators of the
procedure.
Study Protocol
Radiofrequency energy was delivered by a gen-
erator that delivered a continuous, unmodulated
sine wave output at 5(K) kHz, and had a maximum
output of 50 W (EP Technologies). The radiofre-
quency generator required manual modulation of
power. This device was interfaced with a personal
computer (Toshiba Electronics, Inc.), which con-
tinuously measured and recorded power, imped-
ance, and, when available, tip temperature, dur-
ing each radiofrequency application. Radiofre-
quency energy was delivered between the 4-mm
distal electrode of the ablation catheter and a large
adhesive electrode positioned over the left scapula.
In protocols 1 and 2, patients were randomly as-
signed to temperature monitoring or impedance mon-
itoring. In patients randomly assigned to tempera-
ture monitoring, only the temperature was displayed
to the operators. The impedance data were recorded
and stored for future analysis. The endpoint for tem-
perature monitoring was manual power modulation
to achieve a measured temperature of 58° to 62°C
at each target site. The power was titrated until ei-
ther the temperature endpoint was attained or the
maximum energy output was delivered (50 W). If
the temperature endpoint was not achieved with
maximum power, then the application was termi-
nated. Previous studies in humans have demonstrated
60°C to be the average effective temperature for ab-
lation of accessory pathways.'^
In the patients randomly assigned to undergo
impedance monitoring in protocols 1 and 2, only
the impedance was measured and displayed. In the
impedance monitoring group, the endpoint for man-
ual titration of power was a 5- to \0-Q decrease
in the measured impedance, which corresponds to
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a temperature of approximately 57°C.* In both pro-
tocols, the power was titrated until the imped-
ance change endpoint was achieved or until the
maximum power (50 W) was delivered. If the end-
point was not achieved with maximum power, then
the application was terminated. In protocol 2, im-
pedance monitoring was performed with the ther-
mistor catheter. However, only the impedance mea-
surements and not the temperature measurements
were displayed to the operators. The temperature
data were recorded and stored for future analysis.
In a prior study, coagulum formation was never
associated with a < lO-fi decrement in measured
impedance, but was observed in 10% of applica-
tions associated with a > \0-Q, decrement.* Pre-
liminary results fi'om another study were similar.'̂
Therefore, for patients randomized to impedance
monitoring, the power at each target site was man-
ually regulated to achieve an impedance decrement
of 5 to 10 Q, from the initial impedance value for
each application.
The initial power setting was 10 to 25 W irre-
spective of the randomization. Titration of power
to achieve the appropriate endpoint was continued
throughout the energy application, even if loss of
accessory pathway conduction was observed be-
fore the endpoint was reached. Applications of ra-
diofrequency energy were continued for at least
10 seconds after the target temperature or target
impedance was reached. If interruption of acces-
sory pathway conduction was observed, the energy
was applied for a total of 30 to 60 seconds.
Success of the procedure, procedure duration,
fluoroscopy time, number of radiofrequency ap-
plications, and number of applications of energy
associated with coagulum formadon were recorded
for each padent. A successful procedure was defined
as complete eliminadon of accessory pathway con-
duction. The ablation procedure duration was
defined as the dme required to perform the pro-
cedure after the diagnosis was established and un-
dl the final application of radiofrequency energy.
If accessory pathway conducdon was present af-
ter 15 applicadons of energy, an alternate catheter
could be selected. If a catheter type different fTom
that assigned was used, the procedure was con-
sidered unsuccessful.
Statistical Analysis
Condnuous variables are expressed as mean ±
1 SD. Nominal variables were compared by Chi-
square analysis, and condnuous variables were
compared using a t-test for unpaired variables or
a Student's t-test for paired variables, as appro-
priate. The reladonship between condnuous vari-
ables was assessed with regression analysis. Prob-




The success rate of ablation was 93% in pa-
tients assigned to impedance monitoring, which
was not statisdcally different from the 93% suc-
cess rate in patients assigned to temperature
monitoring (Table 3; P = 1.0). After crossover, the
procedure was eventually successful in each pa-
dent. The mean procedure duradon (57 ± 56 vs 41
± 41 min; P = 0.8) and fluoroscopy time (48 ±
29 vs 41 ± 23 min; P = 0.3) in padents random-
ized to impedance and temperature monitoring, re-
specdvely, were not stadsdcally diflerent. The mean
number of radiofrequency applicadons in patients
undergoing impedance monitoring was 6.2 ± 4.7,
compared to 5.7 ± 4.6 in padents randomized to
impedance monitoring (P = 0.8). There was also
no difference in the mean number of applicadons
associated with coagulum formadon between the
impedance monitoring group (0.1 ± 0.3) and the
temperature monitoring group (0.3 ± 0.6; P = 0.1).
There was no significant difference in success
rate, procedure duradon, fluoroscopic dme, num-
ber of applicadons of energy, or frequency of co-
agulum formadon for padents with right-sided, left-
sided, or posteroseptal accessory pathways who
were randomized to impedance monitoring or tem-
perature monitoring.
For patients assigned to temperature monitor-
ing, the mean steady-state temperature of all ap-
plicadons was 56° ± 12°C, while the mean steady-
TABLE 3
Results of Catheter Ablation Guided by
Impedance or Temperature Monitoring: Protocol I
Impedance Temperature
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State temperature for successful applications of en-
ergy was 62° ± 10°C, compared to 55° ± 13°C for
unsuccessful applications (P = 0.01). The mean
change in impedance for all applications was -6.4
± 7.5 fl. Unsuccessful applications of energy were
associated with a measured change in impedance
of -6.1 ± 7.5 Q, while applications associated with
elimination of accessory pathway function were
associated with an impedance change of -8.5 ±
4.8 Q (P = 0.006). The change in impedance dur-
ing successful applications of energy in the im-
pedance and temperature groups were similar (—9.1
± 4.5 n vs -7.8 ±5.1 n, respectively; P = 0.2).
A highly significant correlation between the change
in impedance and the mean steady-state tempera-
ture was observed (R = 0.6, P < 0.0001). Appli-
cations of energy associated with coagulum for-
mation were associated with a change in measured
impedance of -10.0 ± 4.4 Q, while applications
without coagulum formation were associated with
a change in measured impedance of -6.2 ± 7.3 fl
(P = 0.02). The mean temperature associated
with coagulum formation was 98° ± 18°C. The
mean impedance change observed immediately
prior to the coagulum formation was -13.0 ± 1.9
fl in the impedance monitoring groups and -12.9
± 2.2 fl in the temperature monitoring group.
Protocol 2
In protocol 2, the success rate of ablation was
91% in patients assigned to impedance monitor-
ing, which did not differ significantly from the
95% success rate in patients assigned to temper-
ature monitoring (Table 4; P = 1.0). The mean
procedure duration (49 ± 37 vs 62 ± 55 min; P -
0.4) and fiuoroscopic time (46 ± 24 vs 49 ± 36
min; P = 0.8) in patients randomized to imped-
ance monitoring and temperature monitoring, re-
Results 1
TABLE 4
af Catheter Ablation Guided by


































spectively, were not statistically different. The
mean number of radiofrequency applications in
patients undergoing impedance monitoring was
6.8 ± 7.0, compared to 7.8 ± 12.1 in patients
randomized to temperature monitoring (P = 0.7).
Additionally, there was no difference in the fre-
quency of applications associated with coagulum
formation in the impedance monitoring group (0.3
± 0.6) and the temperature monitoring group (0.2
± 0.7; P = 0.6).
When the results were analyzed on the basis
of accessory pathway location, there were no sta-
tistically significant difference in the success rate,
procedure duration, fluoroscopic time, number of
radiofrequency energy applications, or number of
coagulum fonnation between patients randomized
to impedance or temperature monitoring.
The mean steady-state temperature for all ap-
plications of radiofrequency energy for patients
assigned to protocol 2 was 53° ± 8°C. The mean
steady-state temperature of applications in patients
assigned to impedance monitoring (53° ± 8°C)
was not significantly different than in the patients
assigned to temperature monitoring (53° ± 8°C;
P = 0.8). The mean steady-state temperature of
successful applications of radiofrequency energy
was 57° ± 7°C and was significantly greater than
the 52° ± 7°C for unsuccessful applications of en-
ergy (P < 0.001). The mean steady-state tem-
perature attained during successful applications of
radiofrequency energy in the impedance moni-
tored group (57° ± 7°C) was not significantly dif-
ferent than in the temperature monitored group
(57° ± 8°C; P = 0.8). Likewise, the mean
steady-state unsuccessful temperature was statis-
tically similar between groups (P = 1.0). The mean
change in impedance was -A.I ± 0.44 fl for all
applications of energy. The mean change in im-
pedance was -7.8 ± 2.7 fl for successful appli-
cations of energy and -3.5 ± 4.0 fl for unsuc-
cessful applications of energy (P < 0.01). In the
impedance monitoring group, the mean change in
impedance for successful energy applications was
—8.5 ± 1.4 fl, and in the temperature monitoring
group was —7.1 ± 3.4 Q (P = 0.4). The mean im-
pedance change in the impedance monitoring group
(-3.2 ± 4.4 fl) was statistically similar to that in
the temperature monitoring group (-^.3 ± 3.7 f2,
P — 0.1). A significant correlation between the
mean change in impedance and the mean
steady-state temperature was observed in the im-
pedance monitoring group (R = 0.5, P = 0.0001)
and in the temperature monitoring group (R = 0.7,
P < 0.0001).
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Achievement of Titration Endpoints
A total of 843 applications of energy were ap-
plied during ablation of patients assigned to pro-
tocols 1 and 2. For all the patients assigned to im-
pedance monitoring, the power titration goal of an
impedance change of -5 to -10 $7 was achieved
in 47% of the applications. Likewise, for the pa-
tients assigned to temperature monitoring, the end-
point of manual titration of power to obtain a tem-
perature of 60°C was attained in 51 % of applica-
tions (P = 0.3).
Discussion
Main Findings
Power titration during radiolrequency ablation
of accessory pathways guided by temperature or
impedance monitoring was associated with a
similar success rate, number of applications of
radiofrequency energy, incidence of coagulum for-
mation, fluoroscopy duration, and procedure du-
ration. This was true regardless of whether the
same catheter or different catheters were used for
temperature and impedance monitoring, indicating
that differences in the handling characteristics of
the catheters did not affect the results of the study.
Therefore, the results of this study demonstrate that
impedance monitoring and temperature monitor-
ing are equally effective guides for power titration
in patients undergoing radiofrequency ablation of
an accessory pathway.
Temperature and Impedance Data
In protocol 2, the mean temperatures observed
during all applications of radiofrequency energy
were the same between groups, as were the aver-
age temperatures during successful and unsuc-
cessful applications. The mean successful tem-
perature of approximately 60°C was similar to that
already reported.' The mean temperature measured
during successful ablation of an accessory path-
way, in both protocols, was approximately 10%
higher than during unsuccessful applications of ra-
diofrequency energy, suggesting that unsuccessful
applications may be due, at least in part, to inad-
equate tissue contact and insufficient tissue heat-
ing. Despite having a goal for manual power titra-
tion, directed either by impedance or temperature
monitoring, the endpoints could be attained in only
50% of energy applications. This result suggests
that inadequate tissue contact is frequently re-
sponsible for insufficient heating at the electrode-
tissue interface and that inadequate tissue contact
is a common occurrence.
The temjjeratures associated with successful and
unsuccessful applications of energy in the imped-
ance and temperature monitoring groups of pro-
tocol 2 were statistically similar. These results val-
idate the utility of impedance monitoring to accu-
rately predict tissue temperatures of 60°C.
Advantages and Disadvantages of Temperature and
Impedance Monitoring
Both impedance and temperature monitoring are
associated with advantages and disadvantages. First,
the list price of catheters with temperature moni-
toring capabilities is approximately 10% to 30%
more than that of catheters with only impedance
monitoring capabilities. In an environment where
cost is an issue, impedance monitoring may offer
an advantage. Some thermistor catheter designs
may increase the diameter of the catheter, and this
may be a disadvantage in pediatric patients. At the
present time, catheters with multiple ablation elec-
trodes are being developed to make long linear le-
sions for the catheter-based treatment of atrial fibril-
lation. "'•'̂  Equipping these types of catheters with
thermometry capabilities may be technically difficult
and expensive. For these types of catheter designs,
impedance monitoring may be more feasible and
practical. On the other hand, impedance monitor-
ing may not be feasible with some radiofrequency
energy generators. Impedance monitoring is difficult
to use with a generator that has an analog scale,
or that displays impedance values that fiuctuate
widely from moment to moment.
Coagulum Formation
A previous multicenter study^ reported the re-
sults of radiofrequency catheter ablation of the AV
junction, AV nodal reentrant tachycardia, and/or
an accessory pathway in 270 patients. In that study,
a 1.8% incidence of coagulum fonnation was re-
ported. The incidence of coagulum fonnation was
greatest with fixed power applications, and the fre-
quency of coagulum fonnation decreased signifi-
cantly when a closed loop temperature monitoring
system was used.̂  The incidence of coagulum for-
mation in the present study was somewhat higher
than in the study of Calkins et al., perhaps because
power was titrated manually.
In the present study, coagulum formation at times
occurred with temperature and impedance moni-
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toring, despite the fact that both provide an as-
sessment of tissue heating.'̂ -fiî  Two explanations
are possible. The first is that manual titration of
power may result in coagulum formation because
of slow operator responsiveness. The second is that
each of these techniques may sometimes fail to
predict coagulum formation. Both explanations
likely play a role. For instance. Calkins et al.
demonstrated that even with closed loop temper-
ature monitoring, coagulum formation was more
likely to occur when temperatures > 70°C were
targeted. Therefore, targeting temperatures of ap-
proximately 60°C with a closed loop temperature
monitoring system may further decrease the fre-
quency of coagulum formation.
Limitations
All of the patients in this study had an acces-
sory pathway. Therefore, it is unclear whether the
results apply to ablation of other arrhythmias such
as AV nodal reentrant tachycardia or ventricular
tachycardia is not established.
Clinical Implications
Each of these techniques (impedance and tem-
perature monitoring) has advantages. To use either
technique effectively one needs adequate experi-
ence. As the results of the present study demon-
strate, these two techniques are comparable and
independent of the particular catheters used. Be-
cause the handling characteristics of catheters with
and without thermistors may be different, famil-
iarity with both techniques is important to maxi-
mize the results of radiofrequency catheter abla-
tion of accessory pathways.
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